FDA Approves LEUCOVORIN CALCIUM — Ingenus Pharmaceuticals, LLC

# FDA Approves Ingenus Pharmaceuticals' Oral Leucovorin Calcium Generic Ingenus Pharmaceuticals, LLC has received FDA approval for oral leucovorin calcium (ANDA211132), expanding the competitive generic market for this critical supportive care medication used alongside chemotherapy and methotrexate treatments. The approval is expected to increase price competition and improve patient access to this widely-used oncology support drug.